Skip to main content
SpringerLink
Log in

Analysing treatment trends and costs for hip or knee OA in Japan

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was sponsored by Pfizer Japan Inc.

Reference

  • Ebata-Kogure N, et al. Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019. Clinical Drug Investigation : 23 Sep 2020. Available from: URL: https://doi.org/10.1007/s40261-020-00968-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Analysing treatment trends and costs for hip or knee OA in Japan. PharmacoEcon Outcomes News 863, 3 (2020). https://doi.org/10.1007/s40274-020-7157-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7157-y

Search

Navigation